News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed Announces Updated Data of AFM13 in Combination with Keytruda® (Pembrolizumab) in Patients with Relapsed/Refractory Hodgkin Lymphoma Presented at EHA

June 15, 2018

Affimed to Present at the Jefferies Global Healthcare Conference

May 30, 2018

Affimed Announces Annual General Meeting of Shareholders

May 18, 2018

Affimed Reports Financial Results for First Quarter 2018

May 15, 2018

Affimed Announces First Quarter 2018 Financial Results and Corporate Update Conference Call

May 8, 2018

Affimed to Present at Deutsche Bank's 43rd Annual Health Care Conference

May 3, 2018

Affimed Introduces ROCK™ Platform for Tailored Immune Cell Engagers

May 3, 2018

Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy

April 16, 2018

Affimed Reports Financial Results for Fourth Quarter and Year End 2017

March 20, 2018

Affimed Appoints Dr. Leila Alland as Chief Medical Officer

March 19, 2018

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Events

All

Scientific

Investors

30Sep

NK2019

September 30 - October 3, 2019 (Luxembourg)

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.